UofL chosen to turn engineering innovations into medical solutions

September 23, 2011

University of Louisville bioengineering researchers will use a $3.33 million award from the Wallace H. Coulter Foundation to help commercialize promising academic innovations into medical solutions to benefit patients.

The five-year Coulter Translational Partnership Award has the ultimate goal of focusing on outcomes to save, extend and improve patients' lives. With the university's $1.67 million contribution, UofL's program will have a $1 million operating budget for each of the five years. UofL is one of about 15 institutions to participate in this Coulter program.

"When we support university researchers, we create a vigorous hub for life science and engineering businesses to create jobs, change lives and increase our intellectual capital," UofL President James Ramsey said. "Our university has long been and will continue to be committed to translating research from the laboratory bench-top to the bedside."

The Coulter Foundation will form a working partnership with UofL's bioengineering department to promote translational research. The key UofL partners will be J.B. Speed School of Engineering, through Robert Keynton, the lead researcher and bioengineering department chair; the School of Medicine, through Mark Slaughter, M.D., chief of thoracic and cardiovascular surgery; and the Office of Technology Transfer, through Holly Clark and Melea East, interim co-directors. An oversight committee of industry representatives, entrepreneurs, venture capitalists and clinical doctors will be established.

Three UofL bioengineering faculty members - Andre Gobin, Ayman El-Baz and Palaniappan Sethu - are previous Coulter Translational Research Award (career award) recipients.
-end-
For more information, contact Keynton at 502-852-4436 or rob.keynton@louisville.edu

University of Louisville

Related Engineering Articles from Brightsurf:

Re-engineering antibodies for COVID-19
Catholic University of America researcher uses 'in silico' analysis to fast-track passive immunity

Next frontier in bacterial engineering
A new technique overcomes a serious hurdle in the field of bacterial design and engineering.

COVID-19 and the role of tissue engineering
Tissue engineering has a unique set of tools and technologies for developing preventive strategies, diagnostics, and treatments that can play an important role during the ongoing COVID-19 pandemic.

Engineering the meniscus
Damage to the meniscus is common, but there remains an unmet need for improved restorative therapies that can overcome poor healing in the avascular regions.

Artificially engineering the intestine
Short bowel syndrome is a debilitating condition with few treatment options, and these treatments have limited efficacy.

Reverse engineering the fireworks of life
An interdisciplinary team of Princeton researchers has successfully reverse engineered the components and sequence of events that lead to microtubule branching.

New method for engineering metabolic pathways
Two approaches provide a faster way to create enzymes and analyze their reactions, leading to the design of more complex molecules.

Engineering for high-speed devices
A research team from the University of Delaware has developed cutting-edge technology for photonics devices that could enable faster communications between phones and computers.

Breakthrough in blood vessel engineering
Growing functional blood vessel networks is no easy task. Previously, other groups have made networks that span millimeters in size.

Next-gen batteries possible with new engineering approach
Dramatically longer-lasting, faster-charging and safer lithium metal batteries may be possible, according to Penn State research, recently published in Nature Energy.

Read More: Engineering News and Engineering Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.